{
    "nctId": "NCT02823808",
    "officialTitle": "Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function After Early Intensive Diabetes Treatment",
    "inclusionCriteria": "* Type 2 Diabetes Mellitus patients\n* Patient who had been diagnosed within the previous 12 months with HbA1c levels of 8.0-12.0%, did not have a medical history related to diabetes, and did not display proliferative retinopathy\n* Must have minimum age of 26 Years\n* Must have maximum age of 70 Years",
    "exclusionCriteria": "* The use of weight-lowering drugs, any investigational blood-glucose or lipid-lowering agent (other than statins or ezetimibe) within the past 3 months\n* Previous treatment with systemic corticosteroids or a change in dosage of thyroid hormones in the previous 6 weeks\n* The use of insulin within the 3 months prior to screening\n* Others"
}